leisure time -WSS

leisure time

author：explore 2025-10-02 07:01:30 - browse：11

LONDON — AstraZeneca said Tuesday it would acquire Fusion Pharmaceuticals in a deal worth more than $2 billion, picking up a company focused on the booming area of targeted radiation therapies for cancer.

AstraZeneca will pay $2 billion in cash upfront for Fusion, a price that at $21 a share is nearly double Fusion’s closing share price on Monday. If certain regulatory milestones are met, AstraZeneca will pay another $3 a share, or roughly $400 million.

Fusion specializes in developing radiopharmaceuticals, also known as radioconjugates or radioligands, which deliver radiation directly to tumors, guided by particular markers on cancer cells. The aim is not only to minimize the risk of damaging surrounding, healthy tissue, but also to reach tumors that traditional radiation can’t.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： What affirmative action's end means to a medical student

WSS

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

It's time to get medical device identifiers over the finish line

Crowdfunding for unproven stem cell procedures spreads misinformation

New research casts further doubt on a common procedure used with IVF

hotspot

leisure time

knowledge

Alkermes shareholders re

'Screen and refer' systems are hurting patients

Wildfire smoke exposes gaps in outdoor worker protections

Bulgari apologizes to China for listing Taiwan as a country after online backlash

New air purifier tech could be key to improving indoor air quality

New research casts further doubt on a common procedure used with IVF

Activists slam private health insurers over coverage restrictions

Skip the lead apron during X

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Retired US general questions alleged Putin, Prigozhin meeting

Wikipedia

What to know about OceanGate, the company behind the missing Titanic submersible

Canadians with cystic fibrosis outlive Americans by a decade

The wait for US passports is creating travel purgatory and snarling summer plans

Being 'nonadherent' patient made me a more empathetic doctor

Dexcom's push to bring CGM to type 2 diabetes patients

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

entertainment

focus

hotspot

Wikipedia